Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Guidelines for PDT in Japan.

× No keyword cloud information.

16 in total

1. Factors influencing visual outcome of polypoidal choroidal vasculopathy one year after photodynamic therapy.

Authors: Ryusaburo Mori; Mitsuko Yuzawa; Zeon Lee; Miho Haruyama; Eriko Akaza
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2010-03-30 Impact factor: 3.117

2. Photodynamic therapy alone versus combined with intravitreal bevacizumab for neovascular age-related macular degeneration without polypoidal choroidal vasculopathy in Japanese patients.

Authors: Ryuhei Hara; Takahiro Kawaji; Yasuya Inomata; Jin Tahara; Nina Sagara; Mikiko Fukushima; Hidenobu Tanihara
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2010-03-10 Impact factor: 3.117

3. Choroidal thickness outside the laser irradiation area after photodynamic therapy in polypoidal choroidal vasculopathy.

Authors: Yukinori Sugano; Tomohiro Iida; Ichiro Maruko; Akira Ojima; Tetsuju Sekiryu
Journal: Jpn J Ophthalmol Date: 2013-02-14 Impact factor: 2.447

4. Two-year results of combined intravitreal ranibizumab and photodynamic therapy for polypoidal choroidal vasculopathy.

Authors: Masaaki Saito; Tomohiro Iida; Mariko Kano; Kanako Itagaki
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2013-04-05 Impact factor: 3.117

5. Two-year visual outcome of polypoidal choroidal vasculopathy treated with photodynamic therapy combined with intravitreal injections of ranibizumab.

Authors: Masayuki Hata; Akitaka Tsujikawa; Masahiro Miyake; Kenji Yamashiro; Sotaro Ooto; Akio Oishi; Isao Nakata; Ayako Takahashi; Nagahisa Yoshimura
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2014-05-30 Impact factor: 3.117

6. Macular function evaluated by focal macular electroretinograms after reduced fluence photodynamic therapy in eyes with polypoidal choroidal vasculopathy.

Authors: Shigeki Machida; Tomoharu Nishimura; Kunifusa Tamada; Tomomi Harada; Daijiro Kurosaka
Journal: Doc Ophthalmol Date: 2011-12-31 Impact factor: 2.379

7. Two-year results of intravitreal ranibizumab for polypoidal choroidal vasculopathy with recurrent or residual exudation.

Authors: M Saito; T Iida; M Kano; K Itagaki
Journal: Eye (Lond) Date: 2013-06-07 Impact factor: 3.775

8. Photodynamic therapy combined with intravitreal bevacizumab and sub-tenon triamcinolone acetonide injections for age-related macular degeneration.

Authors: Chikako Yoshizawa; Wataru Saito; Shigeki Hirose; Hirokuni Kitamei; Kousuke Noda; Susumu Ishida
Journal: Jpn J Ophthalmol Date: 2012-10-24 Impact factor: 2.447

9. Five-year results of photodynamic therapy with and without supplementary antivascular endothelial growth factor treatment for polypoidal choroidal vasculopathy.

Authors: Masaaki Saito; Tomohiro Iida; Mariko Kano; Kanako Itagaki
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2013-08-07 Impact factor: 3.117

10. Treatment results at 1 year of ranibizumab therapy for polypoidal choroidal vasculopathy in eyes with good visual acuity.

Authors: Ryusaburo Mori; Mitsuko Yuzawa; Eriko Akaza; Miho Haruyama
Journal: Jpn J Ophthalmol Date: 2013-05-11 Impact factor: 2.447